Varanasi Roja, Srivastava Amit, Kumar Rt Shaji, Bala Renu
Central Council for Research in Homoeopathy, New Delhi, Jawahar Lal Nehru Bhartiya Chikitsa Avum Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opposite D-Block, Janakpuri, New Delhi 110058, India.
Regional Research Institute for Homoeopathy, (Under Central Council for Research in Homoeopathy, New Delhi), New Checkon, Opposite Tribal Colony, Imphal East, Manipur 795001, India.
J Ayurveda Integr Med. 2023 Sep-Oct;14(5):100787. doi: 10.1016/j.jaim.2023.100787. Epub 2023 Sep 24.
Studies have shown homoeopathy to effectively control blood sugar levels and improve quality of life (QOL), though a standard treatment protocol is required.
This study intended to assess the homoeopathic practice, prescription habits, experience, and perception of Indian Homeopathic Practitioners (HPs) in treating DM.
A web-based cross-sectional with a snowball sampling method was conducted between 30th July 2021 and 18th August 2021. A questionnaire to record clinical attributes of Indian HPs in the management of DM was formed after the consensus of the subject experts and pilot testing for feasibility.
Participants were 513 HPs with mean age [Standard Deviation (SD)] of 40.44 years (11.16) and a mean duration of the homoeopathic medical practice of 14.67 years [95% Confidence Interval (CI) = 13.71-15.63]. The majority of HPs made classical homoeopathic prescription (201, 39.2%) though the success in the management of DM was better among HPs who prescribed more than one potentized medicine [vs classical prescription, Odds Ratio (OR) = 2.34, p = 0.032]. As perceived by the HPs, homoeopathic treatment resulted in a major improvement in QOL of the diabetic patients (418, 81.5%) with very few adverse effect (100, 19.5%). The blood sugar level was controlled better when homoeopathy was given alongside conventional medicine (348, 67.8%).
The clinical experience of HPs in this study has shown that homoeopathic treatment can benefit DM patients in preventing complications and improving QOL. It further reported that homoeopathy can be an important adjuvant to conventional treatment in managing DM.
研究表明顺势疗法能有效控制血糖水平并改善生活质量（QOL），不过仍需要一个标准治疗方案。
本研究旨在评估印度顺势疗法从业者（HP）在治疗糖尿病方面的顺势疗法实践、处方习惯、经验及看法。
于2021年7月30日至2021年8月18日采用基于网络的横断面研究及雪球抽样方法。在主题专家达成共识并进行可行性预试验后，形成了一份记录印度HP在糖尿病管理中临床特征的问卷。
参与者为513名HP，平均年龄[标准差（SD）]为40.44岁（11.16），顺势疗法医疗实践的平均时长为14.67年[95%置信区间（CI）=13.71 - 15.63]。大多数HP采用经典顺势疗法处方（201名，39.2%），不过在处方一种以上增效药物的HP中，糖尿病管理的成功率更高[与经典处方相比，优势比（OR）=2.34，p = 0.032]。在HP看来，顺势疗法治疗使糖尿病患者的生活质量有了显著改善（418名，81.5%），不良反应极少（100名，19.5%）。顺势疗法与传统药物同时使用时，血糖水平控制得更好（348名，67.8%）。
本研究中HP的临床经验表明，顺势疗法治疗可使糖尿病患者在预防并发症和改善生活质量方面受益。研究还进一步报告称，顺势疗法在糖尿病管理中可成为传统治疗的重要辅助手段。
